Brief: Ryvu Therapeutics Secures Supply Chain For River-81 Study For About EUR 3.9 Mln

Ryvu Therapeutics SA

31/07/2023 07:45

July 31 (Reuters) - Ryvu Therapeutics SA  RVU.WA :
    * SIGNS DEAL WITH CLINICAL SERVICES INTERNATIONAL ON
SECURING
SUPPLY CHAIN OF WENETOKLAKS (VENETOCLAX) MEDICINE FOR RIVER-81
CLINICAL STUDY
    * SAID DEAL CONCLUSION AIDS ACHIEVING OF GOALS SET IN GROWTH
PLANS
FOR 2022-2024
    * TOTAL VALUE OF SAID DEAL AMOUNTS TO ABOUT EUR 3.94 MILLION
    * IN CASE OF SINGING OF DEAL WITH POLAND'S MEDICAL RESEARCH
AGENCY
COSTS CONNECTED TO DEAL ON SECURING SUPPLY CHAINS TO BE
CO-FINANCED BY AGENCY
    * RIVER-81 STUDY IS PLANNED TO COMMENCE IN H2

Source text for Eikon:  ID:nEM5m74Bxa 
Further company coverage:  RVU.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))